2.87
Galecto Inc stock is traded at $2.87, with a volume of 107.83K.
It is up +2.50% in the last 24 hours and down -12.55% over the past month.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.
See More
Previous Close:
$2.80
Open:
$2.72
24h Volume:
107.83K
Relative Volume:
1.25
Market Cap:
$3.80M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-1.9793
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
-4.65%
1M Performance:
-12.55%
6M Performance:
-29.14%
1Y Performance:
-79.72%
Galecto Inc Stock (GLTO) Company Profile
Name
Galecto Inc
Sector
Industry
Phone
45-70-70-52-10
Address
75 STATE STREET, BOSTON
Compare GLTO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GLTO
Galecto Inc
|
2.87 | 3.95M | 0 | -38.35M | -36.91M | -1.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-26-21 | Resumed | Credit Suisse | Outperform |
Nov-23-20 | Initiated | BofA Securities | Buy |
Nov-23-20 | Initiated | Credit Suisse | Outperform |
Nov-23-20 | Initiated | SVB Leerink | Outperform |
Galecto Inc Stock (GLTO) Latest News
Does Galecto Inc. show high probability of reboundEarnings Overview Summary & Daily Profit Maximizing Tips - Newser
Regression analysis insights on Galecto Inc. performance2025 Market WrapUp & Daily Price Action Insights - Newser
Will Galecto Inc. price bounce be sustainableJuly 2025 Decliners & Verified Short-Term Plans - Newser
Short interest data insights for Galecto Inc.Quarterly Market Review & Technical Confirmation Alerts - Newser
Key metrics from Galecto Inc.’s quarterly dataDollar Strength & Low Drawdown Momentum Ideas - Newser
What’s next for Galecto Inc. stock priceWeekly Profit Recap & Reliable Volume Spike Alerts - Newser
Developing predictive dashboards with Galecto Inc. data2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Combining machine learning predictions for Galecto Inc.CEO Change & Smart Allocation Stock Reports - Newser
What machine learning models say about Galecto Inc.Trade Risk Report & Capital Efficiency Focused Ideas - Newser
Galecto Inc. stock prediction for this weekPortfolio Performance Report & Low Drawdown Investment Strategies - Newser
What earnings revisions data tells us about Galecto Inc.CPI Data & Weekly Return Optimization Plans - Newser
Published on: 2025-09-11 19:13:31 - Newser
Combining machine learning predictions for Galecto IncJuly 2025 PreEarnings & Precise Buy Zone Identification - Newser
does galecto inc. show high probability of reboundTrade Signal Summary & Daily Profit Maximizing Tips - Newser
Real time social sentiment graph for Galecto Inc.July 2025 Opening Moves & Daily Momentum Trading Reports - Newser
Is it too late to sell Galecto Inc.Quarterly Trade Review & AI Forecast for Swing Trade Picks - Newser
Can volume confirm reversal in Galecto Inc.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser
How to integrate Galecto Inc. into portfolio analysis toolsMarket Sentiment Report & AI Forecast for Swing Trade Picks - Newser
Will Galecto Inc. stock go up soonLong Setup & Daily Volume Surge Trade Alerts - Newser
What is Galecto Inc.’s valuation compared to sector2025 Market Outlook & Accurate Entry and Exit Point Alerts - Lancaster City Council
Morning Market Movers: DSY, WOLF, ZONE, TRML See Big Swings - RTTNews
Is Galecto Inc. still worth holding after the dipWeekly Trend Report & Proven Capital Preservation Tips - Newser
What to do if you’re stuck in Galecto Inc.M&A Rumor & Fast Entry Momentum Alerts - Newser
Will Galecto Inc. Bounce From 52 Week LowDollar Strength & Real-Time Chart Breakout Alerts - beatles.ru
Real time pattern detection on Galecto Inc. stock2025 Big Picture & Advanced Swing Trade Entry Plans - Newser
Can Galecto Inc. rally from current levelsJuly 2025 Drop Watch & High Return Trade Opportunity Guides - Newser
How to manage a losing position in Galecto Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - Newser
Watch for Trend Continuation in Galecto Inc. Next WeekJuly 2025 Recap & Weekly Market Pulse Updates - beatles.ru
Published on: 2025-09-08 09:05:31 - Newser
What’s the recovery path for long term holders of Galecto Inc.Market Risk Report & Reliable Price Breakout Signals - Newser
Advanced analytics toolkit walkthrough for Galecto Inc.Layoff News & Weekly Momentum Stock Picks - Newser
Can Galecto Inc. deliver alphaQuarterly Market Review & Fast Gaining Stock Strategy Reports - 뉴스영
Galecto Inc Stock (GLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):